to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia

NCT02056847 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

313

Enrollment

INDUSTRY

Sponsor class

Conditions

HbA1c Level Associated With Lipid Compositions

Interventions

DRUG: Pitavastatin calcium 4mg
DRUG: Pitavastatin calcium 2mg

Sponsor

JW Pharmaceutical

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]